Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 192,556 | 201,150 | 129,596 | 139,417 | 143,093 |
| Receivables | N/A | 5,439 | 1,401 | 236 | N/A |
| Other current assets | 1,966 | 0 | 0 | 0 | 503 |
| TOTAL | $194,522 | $206,589 | $130,997 | $139,653 | $143,596 |
| Non-Current Assets | |||||
| PPE Net | 3,570 | 3,303 | 3,090 | 2,050 | 2,060 |
| Intangibles | 347 | 403 | 458 | 513 | 567 |
| Other Non-Current Assets | 12,080 | 11,395 | 10,779 | 10,835 | 800 |
| TOTAL | $15,997 | $15,101 | $14,327 | $13,398 | $3,427 |
| Total Assets | $210,519 | $221,690 | $145,324 | $153,051 | $147,023 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,181 | 9,522 | 6,014 | 5,003 | 4,125 |
| TOTAL | $7,889 | $9,892 | $6,320 | $5,603 | $4,743 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,306 | 11,350 | 10,197 | 10,182 | 447 |
| TOTAL | $11,414 | $11,458 | $10,305 | $10,328 | $593 |
| Total Liabilities | $19,303 | $21,350 | $16,625 | $15,931 | $5,336 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,116 | 2,095 | 2,087 | 1,924 | 1,919 |
| Retained earnings | -332,806 | -320,166 | -317,917 | -308,171 | -299,529 |
| TOTAL | $191,216 | $200,340 | $128,699 | $137,120 | $141,687 |
| Total Liabilities And Equity | $210,519 | $221,690 | $145,324 | $153,051 | $147,023 |